MIDRIN
Live / Allowed — Third extension granted (statement of use) (as of 23 Jun 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 21 May 2024 filing date already counts against anyone who files later.
Record
- Serial number
- 98560966
- Mark type
- Word mark
- Filed
- 21 May 2024
- Published for opposition
- 26 Nov 2024
- Attorney of record
- Chelsea G. Swanson
Goods and services
- Class 005 — Pharmaceuticals: Analgesic preparations; Headache treatment preparations
Owner
- Galt Pharmaceuticals, LLC, Atlanta, GA, US
- Galt Pharmaceuticals, LLC, Atlanta, GA, US
Prosecution history
- 24 Jun 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 23 Jun 2026 — SOU EXTENSION 3 GRANTED
- 23 Jun 2026 — SOU EXTENSION 3 FILED
- 23 Jun 2026 — SOU TEAS EXTENSION RECEIVED
- 06 Mar 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 05 Mar 2026 — SOU EXTENSION 2 GRANTED
- 07 Jan 2026 — SOU EXTENSION 2 FILED
- 05 Mar 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 09 Feb 2026 — SOU EXTENSION RECEIVED WITH TEAS PETITION
- 09 Feb 2026 — NOTICE OF REVIVAL - E-MAILED
- 09 Feb 2026 — PETITION TO REVIVE-GRANTED
- 09 Feb 2026 — TEAS PETITION TO REVIVE RECEIVED
- 09 Feb 2026 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 09 Feb 2026 — ABANDONMENT - NO USE STATEMENT FILED
- 20 Jun 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED